Activation of the cGAS–STING pathway has been linked to increased tumor immunogenicity and enhanced dendritic cell activity with varying influence depending on tumor type, stage, and immune microenvironment (Zhou et al., 2023). This evidence concerns the gene STING1 and neoplasm.